このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department

2017年6月23日 更新者:Sean Michael、University of Massachusetts, Worcester
This is a study of emergency physicians' prescribing patterns related to opioid (narcotic) medications. We are trying to determine whether giving providers access to their own prescribing data influences their prescribing patterns.

調査の概要

詳細な説明

Opioid misuse is a known public safety threat and public health problem, both nationwide and in the Commonwealth of Massachusetts. As a part of these efforts, Emergency Department (ED) outpatient prescriptions have been identified as a potential area for improvement. The Massachusetts Hospital Association (MHA), in conjunction with other stakeholders, developed a set of recommendations to address opioid management and prescribing within the ED setting.

This study is timed to coincide with the rollout by UMassMemorial Health Care of a system-wide opioid prescribing practice guideline/policy which mirrors the Massachusetts Hospital Association's guideline. This rollout provides a unique opportunity for a natural experiment related to provider prescribing practices.

This is a quality improvement project with two primary objectives:

  • Improve understanding of physician practice patterns related to emergency department (ED) opioid prescribing
  • Evaluate the effectiveness of providing individual clinician profile data in influencing behavior change among ED providers, as it relates to their opioid prescribing patterns

There are two corresponding specific aims:

  • Quantitatively describe the current state of opioid prescribing by ED clinicians at four UMass Memorial EDs (using prescriptions generated within the ED electronic health information system between February 2014 and the study implementation date). Descriptive statistics being considered for feasibility of study include:
  • Number of opioid prescriptions per hundred patients seen
  • Percentage of total prescriptions written that are opioids
  • Mean or median quantity of pills dispensed per opioid prescription
  • Number of prescriptions for long-acting opioid formulations
  • Evaluate the effect on prescribing practices of providing individual clinicians with their profile data to illustrate their personal opioid prescribing patterns, relative to the de-identified distribution for all other clinicians in the ED group

This project is timed to coincide with the separately planned implementation of a system-wide opioid prescribing guideline. The guideline implementation is an independent event, but we feel that it presents a unique opportunity for a simultaneous experimental intervention to assess whether providing clinicians with their individual data alters their prescribing practices beyond any effect achieved simply by being subject to the new guideline. Data collected from the electronic medical record and clinician self-reported data about their perceptions of their prescribing practices will be used to evaluate both the effect of the guideline implementation (i.e. comparison of prescribing patterns for all clinicians before and after guideline implementation) and the combined effect of guideline implementation plus individual profile intervention (i.e. comparisons across intervention versus control groups).

研究の種類

介入

入学 (実際)

109

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Massachusetts
      • Clinton、Massachusetts、アメリカ
        • UMass Clinton Hospital
      • Marlborough、Massachusetts、アメリカ
        • UMass Memorial Marlborough Hospital
      • Worcester、Massachusetts、アメリカ
        • UMass Memorial Medical Center

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Provider who practices Emergency Medicine in one or more of four UMass-affiliated EDs (UMassMemorial Medical Center, Marlborough Hospital, and Clinton Hospital), including attending physicians, resident physicians, and advanced practice providers (PAs and NPs).
  • Have placed at least one electronic prescription for a medication of interest (namely opioids) in the PulseCheck electronic medical record system during the 12 months prior to the implementation of the opioid guidelines
  • Be actively practicing in a UMass-affiliated ED at time of implementation of the guidelines

Exclusion Criteria:

  • None

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:ヘルスサービス研究
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
介入なし:Control
Providers who are subject only to the routine implementation of clinical practice guidelines without additional experimental intervention
実験的:Intervention
Providers who are subject to routine clinical practice guideline implementation AND receive provider's own individual prescribing data profile intervention ("Individual prescribing data profile and self-assessment")
Prior to receiving his or her individual data profile, each provider in the intervention group will be asked to identify his or her self-assessment of his or her own opioid prescribing practices. Immediately after providing self-perception data, providers will be provided with their true profile data with a visual display of where they fall within the distribution of their peers. All peer data are de-identified.

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
Change in number of opioid prescriptions per hundred patients seen
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention

二次結果の測定

結果測定
時間枠
Change in percentage of total prescriptions written that are opioids
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
Change in median quantity of pills dispensed per opioid prescription
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
Change in number of prescriptions for long-acting opioid formulations
時間枠:Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention
Pre-intervention baseline compared to 1, 2, 3, 6, 9, 12 months post-intervention

その他の成果指標

結果測定
メジャーの説明
時間枠
Self-assessment of decile for number of opioid prescriptions per hundred patients seen
時間枠:Once, at time of enrollment
The provider's self-assessment of their decile of number of opioid prescriptions per hundred patients seen, compared to their peers
Once, at time of enrollment
Self-assessment of decile for percentage of total prescriptions written that are opioids
時間枠:Once, at time of enrollment
The provider's self-assessment of their decile of their percentage of total prescriptions written that are opioids, compared to their peers
Once, at time of enrollment
Self-assessment of decile for median quantity of pills dispensed per opioid prescription
時間枠:Once, at time of enrollment
The provider's self-assessment of their decile of their median quantity of pills dispensed per opioid prescription, compared to their peers
Once, at time of enrollment
Self-assessment of decile for number of prescriptions for long-acting opioid formulations
時間枠:Once, at time of enrollment
The provider's self-assessment of their decile of their number of prescriptions for long-acting opioid formulations, compared to their peers
Once, at time of enrollment

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Sean Michael, MD、UMass Memorial Health Care

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2016年2月1日

一次修了 (実際)

2017年3月1日

研究の完了 (実際)

2017年3月1日

試験登録日

最初に提出

2016年1月20日

QC基準を満たした最初の提出物

2016年1月22日

最初の投稿 (見積もり)

2016年1月27日

学習記録の更新

投稿された最後の更新 (実際)

2017年6月27日

QC基準を満たした最後の更新が送信されました

2017年6月23日

最終確認日

2017年6月1日

詳しくは

本研究に関する用語

キーワード

その他の研究ID番号

  • H00009241

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する